The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro ... alcohol addiction, but the new study says their use can increase higher ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

Oprah Winfrey has recently shared her two cents on thin people after the use of weight loss drug Ozempic. On January 21, Oprah, who is now 72 kg, revealed what it’s like to take a GLP-1 over the ...

You may take Ozempic or another drug to control your diabetes or lose weight, but these so-called GLP-1s also have a host of other effects ‒ some good and some not so good. A new study ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and even potentially lower the risk of opioid overdoses. But now, a new study finds that taking ...

Ozempic was first approved to treat diabetes in Canada seven ... But the U.S. researchers also found new risks associated with GLP-1 use, such as pancreatitis — an inflammation of the pancreas that ...

Blockbuster weight loss drug Ozempic has become a global sensation. Now scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings that works like drugs like ...

Weight-loss drugs like Ozempic may decrease your risk of developing ... most comprehensive studies-of-its-kind to date. Now, in a new study, scientists have compiled what they say is the clearest ...

"This is new territory," said lead researcher Dr Ziyad ... Then, weight loss was noticed as a significant side-effect - and Ozempic and Wegovy became household names. The study used data on ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated between the government and manufacturers.